Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-reactive immunity elicited by oral and parenteral typhoid vaccines against non-typhoid Salmonellae
2009-012949-33Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jun 2009
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of typhoid vaccine, live oral and salmonella typhi capsular polysaccharide vaccine in typhoid fever and nontyphoidal salmonellosis (2 arms), sponsored by Helsinki University Hospital. Primary endpoints: Specific IgA-, IgG-, and IgM-secreting antibody cells, Homing potentials of circulating vaccine antigen-specific antibody-secreting cells and 1 more. Started Jun 2009; status: completed.
02
Drugs
typhoid vaccine, live oralsalmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid fevernontyphoidal salmonellosis
Beyond the preview
Go deeper on 2009-012949-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012949-33.